Fact CheckerSign in

NCT05868668Recruiting

Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain

Randomized Controlled Trial of Focused Shockwave, Radial Wave, and Sham Therapy for Erectile Dysfunction and Focused Shockwave and Sham Therapy for Chronic Pelvic Pain Syndrome in Patients With and Without History of Prostate Cancer

Source: ClinicalTrials.gov · Last updated 19 Aug 2026

Brief summary (registry, in English)

The purpose of this study to perform a randomized, sham controlled analysis of the effectiveness of both fSWT and rWT in the relief of erectile dysfunction and chronic pelvic pain syndrome.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
186 (estimated)
First submitted
11 May 2023
Start date
19 Sept 2023
Primary completion date
Dec 2026
Lead sponsor
The Cleveland Clinic
NCT number
NCT05868668

What you commit to

  • Study type: Interventional
  • Planned participants: 186
  • From 19 Sept 2023 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Untreated hypogonadism (morning total testosterone \<300 ng/dL) or on androgen deprivation therapy in the last 12 months
  • Known corporal veno-occlusive dysfunction based on prior Doppler penile ultrasound
  • Patients currently using SSRI or psychotropic medication

Other illness

  • Nerve-injury related ED (/spinal cord injury, severe lumbosacral disorder (radiculopathy, spinal stenosis) or other neurological disease affecting erectile functions (e.g, multiple sclerosis, alzheimer's disease, parkinsons disease, amyotrophic lateral sclerosis)
  • Peyronie's disease, palpable plaque or curvature/penile anatomic abnormality that affects penetrative intercourse to any degree
  • History of non-superficial penile surgery (e.g, penile prosthesis, penectomy, plication, grafting)
  • History of penile injury or trauma (e.g, priapism, penile fracture)
  • Poorly controlled hypertension
  • Severe cardiac disease or history of myocardial infarction
  • History of psychiatric disorder including bipolar disorder, current moderate or severe depression
  • Current acute prostatitis
    • Chronic Pelvic Pain Syndrome Group:
  • Nerve-injury related pelvic pain (history of /spinal cord injury, severe lumbosacral disorder (radiculopathy, spinal stenosis) or other neurological disease affecting pain in the pelvic region(Multiple sclerosis, Alzheimer's, Parkinsons disease)
  • Acute prostatitis or any acute infection of the pelvic region
  • History of pelvic trauma

Lab values

  • If diabetic, HbA1c 8% or higher within the past 12 months

Other

  • Predominately psychogenic ED based upon expert clinician opinion
  • Use of intracavernosal injection for ED within the last year
  • Current tobacco smoker, or has smoked in the past year
  • Poorly controlled hyperlipidemia
  • Severe ED based on IIEF-EF (score 10 or below)

Who the study is looking for

  • Adult males ≥18 years old
  • Chronic pelvic pain not explained by concurrent urinary tract infections. urine)
  • Willing to do PFPT

Criteria the registry did not label

  • Erectile Dysfunction Group (ED) Inclusion Criteria (ED): (all of the following)
  • Cis-gendered heterosexual adult males18 years old
  • Stable relationship of more than 3 months duration with currently willing sexual partner and desire for penetration.
  • Mild to moderate organic erectile dysfunction (IIEF-EF score 11-25) in the last 3 months
  • If ED responsive or partially responsive to current use of PDE5I, participant must be willing to discontinue PDE5I for 4 weeks prior to trial and remain off PDE5I for the duration of the study. Partially responsive ED is defined as inadequate response for desired sexual activity, or poorly maintained erection despite initially good response.
  • Agreeable to attempt sexual intercourse at least 4 times per month for duration of study without being under the influence of alcohol or recreational drugs
  • Morning total testosterone level over 300ng/dL

Age in the registry: 40 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cleveland Clinic Foundation
Coordinator of this site? Confirm its status
ClevelandUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.